Dementia and Cognitive Disorders
OCTOBER - NOVEMBER 2015
This bi-monthly bulletin covers dementia and cognitive disorders including Alzheimer’s
disease and dementia in Parkinson’s disease.
Many of the following articles are available online via The NHS Scotland Knowledge
Network. Please use the links where provided and your ATHENS password. A complete
list of available online journals and registration for ATHENS can be found at
www.knowledge.scot.nhs.uk
If the article you require is not available via The Knowledge Network and you would
like to request a copy, please submit your request online at www.quest.scot.nhs.uk
This bulletin contains a selection of material gathered from a search of the evidence base,
and is not intended to be comprehensive. Professional judgment should be exercised when
appraising the material. The Library takes no responsibility for the wording, content and
accuracy of the information supplied, which has been extracted in good faith from reputable
sources. NHSGGC is not responsible for the content of external internet sites.
Contents
Page
ALZHEIMER’S DISEASE
DEMENTIA
DEMENTIA IN PARKINSON’S DISEASE
MILD COGNITIVE IMPAIRMENT
2
4
9
10
Compiled by:
Alison McAughtrie
Assistant Librarian
Gartnavel General
T: 0141 211 3013
E: alison.mcaughtrie@ggc.scot.nhs.uk
1
ALZHEIMER’S DISEASE
***Hold Ctrl and click on title to check for abstract and full text – you will need to use
your Athens account***
Alzheimer’s Disease: Exploring the Role of Inflammation and Implications for
Treatment. 2015. International Journal of Alzheimer's Disease, , pp. 1-10 10p.
Cerebrovascular Infarcts Increase the Associated Risk between Diabetes and
Alzheimer's. 2015. Neurology Today, 15(20), pp. 1-4 2p.
Dextromethorphan/Quinidine for Agitation in Alzheimer's
Disease...Dextromethorphan/Quinidine for Agitation in Alzheimer’s Disease.
2015. Neurology Today, 15(21), pp. 9-9 1/2p.
New Ways to Predict Alzheimer's Disease. 2015. Journal of gerontological nursing,
41(11), pp. 7-7 1/5p.
Prevalence of Drug Combinations Increasing Bleeding Risk Among Warfarin Users
With and Without Alzheimer's Disease. 2015. Drugs & aging, 32(11), pp. 937-945 9p.
Smoking and Smoking Increase in Caregivers of Alzheimer's Patients. 2015.
Gerontologist, 55(5), pp. 780-792 13p.
Vigorous exercise may counter cognitive decline in early Alzheimer’s. 2015.
Harvard women's health watch, 23(2), pp. 8-8 3/7p.
What are the Benefits of Exercise for Alzheimer's Disease? A Systematic Review
of the Past 10 Years. 2015. Journal of Aging & Physical Activity, 23(4), pp. 659-668 10p.
Dementia: not all about Alzheimer's. 2015. The Lancet, 386(10004), pp. 1600-1600.
AHMED, S., et al, 2015. Linking insulin with Alzheimer’s disease: Emergence as
type III diabetes. Neurological Sciences, 36(10), pp. 1763-1769.
AMIEVA, H., et al, 2015. Group and individual cognitive therapies in alzheimer's
disease: The etna3 randomized trial. International Psychogeriatrics,
BERTOUX, M., et al, 2015. Discounting of future rewards in behavioural variant
frontotemporal dementia and Alzheimer’s disease. Neuropsychology, 29(6), pp. 933939.
2
BIANCO, O.A.F.M., et al, 2015. Serotoninergic antidepressants positively affect
platelet adam10 expression in patients with alzheimer's disease. International
Psychogeriatrics,
BRUNELLE-HAMANN, L., 2015. Impact of a cognitive rehabilitation intervention on
neuropsychiatric symptoms in mild to moderate Alzheimer's disease.
Neuropsychological Rehabilitation, 25(5), pp. 677-707.
COUPÉ, P., et al, 2015. Detection of alzheimer's disease signature in mr images
seven years before conversion to dementia: Toward an early individual prognosis.
Human brain mapping,
DAULATZAI, M.A., 2015. Olfactory dysfunction: Its early temporal relationship and
neural correlates in the pathogenesis of Alzheimer’s disease. Journal of neural
transmission, 122(10), pp. 1475-1497.
GISPERT, J.D., et al, 2015. Nonlinear cerebral atrophy patterns across the
Alzheimer's disease continuum: Impact of APOE4 genotype. Neurobiology of aging,
36(10), pp. 2687-2701.
HAMELIN, L., et al, 2015. Sulcal morphology as a new imaging marker for the
diagnosis of early onset Alzheimer's disease. Neurobiology of aging, 36(11), pp.
2932-2939.
HASSENSTAB, J., et al, 2015. Neuropsychological markers of cognitive decline in
persons with Alzheimer disease neuropathology. Journal of neuropathology and
experimental neurology, 74(11), pp. 1086-1092.
KHAZAEE, A., et al, 2015. Identifying patients with Alzheimer’s disease using
resting-state fMRI and graph theory. Clinical Neurophysiology, 126(11), pp. 21322141.
KOPONEN, M., et al, 2015. Long-term use of antipsychotics among communitydwelling persons with Alzheimer's disease: A nationwide register-based study.
European Neuropsychopharmacology, 25(10), pp. 1706-1713.
LESOURD, M., et al, 2015. Mechanical Problem-Solving Strategies in Alzheimer’s
Disease and Semantic Dementia. Neuropsychology,
LI, P., et al, 2015. Correlated patterns of neuropsychological and behavioral
symptoms in frontal variant of alzheimer disease and behavioral variant
frontotemporal dementia: A comparative case study. Neurological Sciences,
MARCIANI, D.J., 2015. Alzheimer's disease vaccine development: A new strategy
focusing on immune modulation. Journal of neuroimmunology, 287, pp. 54-63.
MORETTI, D.V., 2015. Association of EEG, MRI, and regional blood flow biomarkers
is predictive of prodromal Alzheimer’s disease. Neuropsychiatric Disease and
3
Treatment, 11
OSSENKOPPELE, R., et al, 2015. Atrophy patterns in early clinical stages across
distinct phenotypes of Alzheimer's disease. Human brain mapping, 36(11), pp. 44214437.
PENOLAZZI, B., et al, 2015. Transcranial direct current stimulation and cognitive
training in the rehabilitation of Alzheimer disease: A case study.
Neuropsychological Rehabilitation, 25(6), pp. 799-817.
REZAZADEH, M., et al, 2015. Genetic factors affecting late-onset alzheimer’s
disease susceptibility. NeuroMolecular Medicine,
SAKAI, M., et al, 2015. Decline of gustatory sensitivity with the progression of
alzheimer's disease. International Psychogeriatrics,
TEIPEL, S., et al, 2015. Multimodal imaging in Alzheimer's disease: Validity and
usefulness for early detection. The Lancet Neurology, 14(10), pp. 1037-1053.
TURNER, R.S., et al, 2015. A randomized, double-blind, placebo-controlled trial of
resveratrol for Alzheimer disease. Neurology, 85(16), pp. 1383-1391.
VITICCHI, G., et al, 2015. Framingham risk score can predict cognitive decline
progression in alzheimer's disease. Neurobiology of aging, 36(11), pp. 2940-2945.
YANG, RUIWANG, QINGJUNLI, FANGLI,JIANLIU, XUEWEN, 2015. Edaravone injection
ameliorates cognitive deficits in rat model of Alzheimer's disease. Neurological
Sciences, 36(11), pp. 2067-2072.
ZHANG, QINGHUAGUO, SHOUGANGZHANG, XIAOTANG, SHISHAO, WENHAN,
XIAOJUANWANG,LUDU, YIFENG, 2015. Inverse relationship between cancer and
Alzheimer's disease: a systemic review meta-analysis. Neurological Sciences,
36(11), pp. 1987-1994.
ZHOU, X. and XU, J., 2015. Identification of Alzheimer’s disease associated long
noncoding RNAs. Neurobiology of aging, 36(11), pp. 2925-2931.
DEMENTIA
***Hold Ctrl and click on title to check for abstract and full text – you will need to use
your Athens account***
Societies can both grow old and lower dementia burden. 2015. The Lancet
Neurology, 14(10), pp. 967-967.
Clinical digest. MORE PROLONGED USE OF DEMENTIA DRUG COULD PROVE TO BE
BENEFICIAL. 2015. Nursing Standard, 30(11), pp. 14-14 1/3p.
4
MIND Diet May Slow Cognitive Decline. 2015. Journal of gerontological nursing,
41(11), pp. 8-8 1/4p.
Raising awareness through film: the themes raised by Still Alice. 2015. Nursing &
Residential Care, 17(11), pp. 638-640 3p.
The importance of diet and nutrition in severe mental health problems. 2015.
Journal of Community Nursing, 29(5), pp. 68-73 5p.
The Montreal Cognitive Assessment: Creating a Crosswalk with the Mini-Mental
State Examination. 2015. Journal of the American Geriatrics Society, 63(11), pp. 23702374 5p.
Uptake of a newly implemented advance care planning program in a dementia
diagnostic service. 2015. Age & Ageing, 44(6), pp. 1045-1049 5p.
AHMED, R.M., et al, 2015. Eating behavior in frontotemporal dementia: Peripheral
hormones vs hypothalamic pathology. Neurology, 85(15), pp. 1310-1317.
ANNEAR, MICHAEL J.TOYE, CHRISTINE M.ECCLESTON, CLAIRE E.MCINERNEY, FRANCES
J.ELLIOTT, KATE-ELLEN J.TRANTER, BRUCE K.HARTLEY, THOMASROBINSON,ANDREW L.,
2015. Dementia Knowledge Assessment Scale: Development and Preliminary
Psychometric Properties. Journal of the American Geriatrics Society, 63(11), pp. 23752381.
ATKINSON, J., et al, 2015. Detecting cognitive impairment and dementia in deaf
people: The British Sign Language Cognitive Screening Test. Archives of Clinical
Neuropsychology, 30(7), pp. 694-711.
BIER, N., et al, 2015. Relying on procedural memory to enhance independence in
daily living activities: Smartphone use in a case of semantic dementia.
Neuropsychological Rehabilitation, 25(6), pp. 913-935.
BORRONI, B., et al, 2015. Early stage of behavioral variant frontotemporal
dementia: Clinical and neuroimaging correlates. Neurobiology of aging, 36(11), pp.
3108-3115.
BRAUN, S.M., et al, 2015. “Interactive surfaces” technology as a potential tool to
stimulate physical activity in psychogeriatric nursing home residents. Disability &
Rehabilitation: Assistive Technology, 10(6), pp. 486-492 7p.
CAO, L., et al, 2015. Dietary patterns and risk of dementia: A systematic review
and meta-analysis of cohort studies. Molecular neurobiology,
CHACKO, E.E., et al, 2015. Reactions to driving cessation: A qualitative study of
people with dementia and their families. Australasian Psychiatry, 23(5), pp. 496-499.
5
CHO, H., et al, 2015. Postmorbid learning of saxophone playing in a patient with
frontotemporal dementia. Neurocase, 21(6), pp. 767-772.
CROSS, N., et al, 2015. Napping in older people ‘at risk’ of dementia: Relationships
with depression, cognition, medical burden and sleep quality. Journal of sleep
research, 24(5), pp. 494-502.
DAIANU, M., et al, 2015. An advanced white matter tract analysis in frontotemporal
dementia and early-onset alzheimer’s disease. Brain Imaging and Behavior,
DONNELLAN, W.J., et al, 2015. What are the factors that facilitate or hinder
resilience in older spousal dementia carers? A qualitative study. Aging & Mental
Health, 19(10), pp. 932-939.
DREGAN, A., et al, 2015. Patterns of anti-inflammatory drug use and risk of
dementia: A matched case–control study. European Journal of Neurology, 22(11), pp.
1421-1428.
DUGMORE, O., et al, 2015. Qualitative studies of psychosocial interventions for
dementia: A systematic review. Aging & Mental Health, 19(11), pp. 955-967.
EDLOW, B.L. and HINSON, H.E., 2015. Blowing the whistle on sports concussions:
Will the risk of dementia change the game? Neurology, 85(17), pp. 1442-1443.
ELDER, G.J., et al, 2015. Depressive symptoms are associated with daytime
sleepiness and subjective sleep quality in dementia with lewy bodies. International
journal of geriatric psychiatry,
FLETCHER, P.D., et al, 2015. Pain and temperature processing in dementia: A
clinical and neuroanatomical analysis. Brain: A Journal of Neurology, 138(11), pp.
3360-3372.
FONSECA, J.A.S., et al, 2015. Factors that predict cognitive decline in patients with
subjective cognitive impairment. International Psychogeriatrics, 27(10), pp. 16711677.
GARCIA-REITBOECK, P., et al, 2015. Prominent cognitive decline and behavioural
disturbance in late-onset Alexander disease. Journal of the neurological sciences,
357(1-2), pp. 319-321.
GEROLIMATOS, L.A., et al, 2015. Development and preliminary evaluation of the
anxiety in cognitive impairment and dementia (ACID) scales. International
Psychogeriatrics, 27(11), pp. 1825-1838.
GIEBEL, C.M., et al, 2015. Understanding the cognitive underpinnings of functional
impairments in early dementia: A review. Aging & Mental Health, 19(10), pp. 859875.
6
GONZALEZ, J., et al, 2015. Reminiscence and dementia: A therapeutic intervention.
International Psychogeriatrics, 27(10), pp. 1731-1737.
GROBER, E., et al, 2015. Conventional and robust norming in identifying preclinical
dementia. Journal of Clinical and Experimental Neuropsychology, 37(10), pp. 1098-1106.
IODICE, R., et al, 2015. Improvement of encoding and retrieval in normal and
pathological aging with word–picture paradigm. Aging & Mental Health, 19(10), pp.
940-946 7p.
JENKINS, E.C., et al, 2015. Telomere longitudinal shortening as a biomarker for
dementia status of adults with down syndrome. American Journal of Medical Genetics
Part B: Neuropsychiatric Genetics,
KAMMINGA, J., et al, 2015. Differentiating between right-lateralised semantic
dementia and behavioural-variant frontotemporal dementia: An examination of
clinical characteristics and emotion processing. Journal of Neurology, Neurosurgery &
Psychiatry, 86(10), pp. 1082-1088.
LAMPIT, A. and VALENZUELA, M., 2015. Pointing the FINGER at multimodal
dementia prevention. The Lancet, 386(10004), pp. 1625-1626.
LANDY, K.M., et al, 2015. Motion discrimination in dementia with Lewy bodies and
Alzheimer disease. Neurology, 85(16), pp. 1376-1382.
LARNER, A.J., 2015. Mini-Addenbrooke's cognitive examination diagnostic accuracy
for dementia: reproducibility study. International journal of geriatric psychiatry,
30(10), pp. 1103-1104.
LLOYD, B.T. and STIRLING, C., 2015. The will to mobility: life-space satisfaction and
distress in people with dementia who live alone. Ageing & Society, 35(9), pp. 18011820 20p.
MALEK-AHMADI, M., et al, 2015. Age- and education-adjusted normative data for
the Montreal Cognitive Assessment (MoCA) in older adults age 70–99. Aging,
Neuropsychology, and Cognition, 22(6), pp. 755-761.
NOGALES-GONZÁLEZ, C., et al, 2015. Moderating effect of self-efficacy on the
relation between behavior problems in persons with dementia and the distress
they cause in caregivers. Aging & Mental Health, 19(11), pp. 1022-1030 9p.
O'BRIEN, J.T. and THOMAS, A., 2015. Vascular dementia. The Lancet, 386(10004), pp.
1698-1706.
ORRELL, M. and BRAYNE, C., 2015. Dementia prevention: Call to action. The Lancet,
386(10004), pp. 1625-1625.
7
PATHAK, K.P. and MONTGOMERY, A., 2015. General practitioners’ knowledge,
practices, and obstacles in the diagnosis and management of dementia. Aging &
Mental Health, 19(10), pp. 912-920.
PEISAH, C., et al, 2015. Knowledge translation regarding financial abuse and
dementia for the banking sector: The development and testing of an education
tool. International journal of geriatric psychiatry,
PHILLIPSON, L., et al, 2015. Dementia attitudes and help-seeking intentions: An
investigation of responses to two scenarios of an experience of the early signs of
dementia. Aging & Mental Health, 19(11), pp. 968-977.
SHIMADA, H.H., 2015. Dementia with Lewy bodies can be well-differentiated from
Alzheimer's disease by measurement of brain acetylcholinesterase activity-a
[(11) C]MP4A PET study. International journal of geriatric psychiatry, 30(11), pp. 11051113.
TONGA, J.B., et al, 2015. Manual-based cognitive behavioral and cognitive
rehabilitation therapy for young-onset dementia: A case report. International
Psychogeriatrics,
VAN MIERLO, L.D., et al, 2015. Tailored mental health care after nursing home
admission: Improving transfers of people with dementia with behavioral
problems. An explorative study. Aging & Mental Health, 19(10), pp. 902-911.
VAN, D.P., et al, 2015. Internet video chat (skype) family conversations as a
treatment of agitation in nursing home residents with dementia. International
Psychogeriatrics,
WALKER, Z., et al, 2015. Lewy body dementias. The Lancet, 386(10004), pp. 16831697.
WATSON, R., et al, 2015. Subcortical volume changes in dementia with lewy bodies
and alzheimer's disease. A comparison with healthy aging. International
Psychogeriatrics,
WOOD, J.H., et al, 2015. Communication and respect for people with dementia:
Student learning (cards) – the development and evaluation of a pilot of an
education intervention for pre-qualifying healthcare students. International
Psychogeriatrics,
WOOLLEY, S.C. and STRONG, M.J., 2015. Frontotemporal dysfunction and dementia
in amyotrophic lateral sclerosis. Neurologic clinics, 33(4), pp. 787-805.
YOUNG, R., et al, 2015. The impact of viewing and making art on verbal fluency and
memory in people with dementia in an art gallery setting. Psychology of Aesthetics,
Creativity, and the Arts, 9(4), pp. 368-375.
8
YU, W.-., et al, 2015. Cataract surgery is associated with a reduced risk of
dementia: A nationwide population-based cohort study. European Journal of
Neurology, 22(10), pp. 1370-1379.
ZUIDEMA, S.U., et al, 2015. A consensus guideline for antipsychotic drug use for
dementia in care homes. Bridging the gap between scientific evidence and clinical
practice. International Psychogeriatrics, 27(11), pp. 1849-1859.
DEMENTIA IN PARKINSON’S
***Hold Ctrl and click on title to check for abstract and full text – you will need to use
your Athens account***
Formulaic Language in Parkinson's Disease and Alzheimer's Disease:
Complementary Effects of Subcortical and Cortical Dysfunction. 2015. Journal of
Speech, Language & Hearing Research, 58(5), pp. 1493-1507 15p.
Screening for Mild Cognitive Impairment in Parkinson’s Disease: Comparison of
the Italian Versions of Three Neuropsychological Tests. 2015. Parkinson's Disease
(20420080), , pp. 1-10 10p.
DE LUCIA, N., et al, 2015. Closing-in in Parkinson’s disease individuals with
dementia: An experimental study. Journal of Clinical and Experimental
Neuropsychology, 37(9), pp. 946-955.
GUERREIRO, R., et al, 2015. Genome-wide analysis of genetic correlation in
dementia with lewy bodies, parkinson's and alzheimer's diseases. Neurobiology of
aging,
HERSHEY, L.A. and PEAVY, G.M., 2015. Cognitive decline in Parkinson disease: How
steep and crowded is the slope? Neurology, 85(15), pp. 1268-1269.
HOBSON, P., JOLYON, 2015. Mild cognitive impairment in Parkinson's disease and
its progression onto dementia: a 16-year outcome evaluation of the Denbighshire
cohort. International journal of geriatric psychiatry, 30(10), pp. 1048-1055.
HOMMA, T., et al, 2015. Medial temporal regional argyrophilic grain as a possible
important factor affecting dementia in Parkinson's disease. Neuropathology, 35(5),
pp. 441-451.
KORCZYN, A.D., 2015. Parkinson's and alzheimer's diseases: Focus on mild
cognitive impairment. Parkinsonism & related disorders,
MAK, E., et al, 2015. Baseline and longitudinal grey matter changes in newly
diagnosed Parkinson’s disease: ICICLE-PD study. Brain: A Journal of Neurology,
138(10), pp. 2974-2986.
NICOLETTI, G., et al, 2015. Role of g-protein coupled receptor kinase 5 gene in
cognitive impairment in parkinson's disease. Psychiatry research,
9
PERAZA, LUIS R.COLLOBY, SEAN J.FIRBANK, MICHAEL J.GREASY, G. SHIRMINMCKEITH,
IAN G.KAISER, MARCUSO'BRIEN,JOHNTAYLOR, JOHN-PAUL, 2015. Resting state in
Parkinson's disease dementia and dementia with Lewy bodies: commonalities
and differences. International journal of geriatric psychiatry, 30(11), pp. 1135-1146.
PIGOTT, K., et al, 2015. Longitudinal study of normal cognition in Parkinson
disease. Neurology, 85(15), pp. 1276-1282.
ROSSI, S. and ULIVELLI, M., 2015. The olfactory side of Parkinson disease:
Relevance for clinical practice. Neurology, 85(15), pp. 1266-1267.
VASCONCELLOS, L.F.R. and PEREIRA, J.S., 2015. Parkinson’s disease dementia:
Diagnostic criteria and risk factor review. Journal of Clinical and Experimental
Neuropsychology, 37(9), pp. 988-993.
MILD COGNITIVE IMPAIRMENT (MCI)
***Hold Ctrl and click on title to check for abstract and full text – you will need to use
your Athens account***
Specialized Brain Proteins Detected in Blood in Individuals With Mild Cognitive
Impairment or Dementia. 2015. Journal of gerontological nursing, 41(11), pp. 7-7 1/4p.
Beverage Consumption Patterns and Micronutrient and Caloric Intake from
Beverages in Older Adults with Mild Cognitive Impairment. 2015. Journal of
Nutrition in Gerontology & Geriatrics, 34(4), pp. 399-409 11p.
Evaluating an accessible web interface for older adults – the impact of mild
cognitive impairment (MCI). 2015. Journal of Assistive Technologies, 9(4), pp. 219-232
14p.
Exercise Increases the Dynamics of Diurnal Cortisol Secretion and Executive
Function in People With Amnestic Mild Cognitive Impairment. 2015. Journal of
Aging & Physical Activity, 23(4), pp. 550-558 9p.
Living With Ambiguity: A Metasynthesis of Qualitative Research on Mild Cognitive
Impairment. 2015. Gerontologist, 55(5), pp. 892-912 21p.
BENAVIDES-VARELA, S., et al, 2015. Anatomical substrates and neurocognitive
predictors of daily numerical abilities in mild cognitive impairment. Cortex: A
Journal Devoted to the Study of the Nervous System and Behavior, 71, pp. 58-67.
GORSKA-CIEBIADA, M., et al, 2015. Adiponectin, leptin and il-1 ß in elderly diabetic
patients with mild cognitive impairment. Metabolic brain disease,
10
OSONE, A., et al, 2015. Impact of lifestyle-related disease on conversion and
reversion in patients with mild cognitive impairment: After 12 months of followup. International journal of geriatric psychiatry,
PEREIRA, ANTONINADE MENDONÇA, ALEXANDRESILVA, DINAGUERREIRO,
MANUELAFREEMAN,JAYNEELLIS, JUDI, 2015. Enhancing prospective memory in mild
cognitive impairment: The role of enactment. Journal of Clinical & Experimental
Neuropsychology, 37(8), pp. 863-877.
PERNIGO, S., et al, 2015. Behavioral and neural correlates of visual emotion
discrimination and empathy in mild cognitive impairment. Behavioural brain
research, 294, pp. 111-122.
RYU, S.Y., et al, 2015. Subjective memory complaints, depressive symptoms and
instrumental activities of daily living in mild cognitive impairment. International
Psychogeriatrics,
SHEPPARD, D.P., et al, 2015. Elevated rates of mild cognitive impairment in HIV
disease. Journal of neurovirology, 21(5), pp. 576-584.
STREET, S.J., et al, 2015. Interaction of erythrocyte eicosapentaenoic acid and
physical activity predicts reduced risk of mild cognitive impairment. Aging & Mental
Health, 19(10), pp. 885-891 7p.
THUNG, K., et al, 2015. Identification of progressive mild cognitive impairment
patients using incomplete longitudinal mri scans. Brain Structure & Function,
Please note that the journal articles you are accessing are subject to the terms and conditions
imposed by the publisher, so there will be a limit on the number of articles an individual may
download or print from a single issue of a journal. You can consult your local NHSGGC
library with any queries.
If you have any questions regarding this or any other library services please contact Library
staff – contact details are at the beginning of the bulletin.
Sources used for this bulletin: Embase, Medline, Cochrane Library, PsychInfo, Psychology
and Behavioural Sciences Collection, CINAHL, WHO, Scottish Government, Alzheimer’s
Society.
11